Centre To Sell Up To 3.5% In HAL, Expected To Fetch Rs 2,800 Crore
The government will sell up to 3.5 per cent stake in Hindustan Aeronautics Ltd (HAL) at a floor price of Rs 2,450 a share, if fully subscribed, would fetch about Rs 2,800 crore to the exchequer. The two-day Offer For Sale (OFS) will open for institutional investors on Thursday and for retail buyers on Friday.
The OFS comprises of base issue size of 1.75 per cent or 58.51 lakh shares, with an option to retain over-subscription of an equal quantum.
"In the event the oversubscription option is exercised, the equity shares forming part of the base offer size and the oversubscription option will represent 3.50 per cent (1,17,03,563) equity shares of the company," HAL said in a regulatory filing.
At the floor price of Rs 2,450 apiece, the sale of 3.5 per cent stake would fetch about Rs 2,800 crore to the exchequer.
The floor price is at a discount of around 6.7 per cent over the closing share price of HAL on the BSE.
Shares of HAL closed 0.93 per cent down at Rs 2,625.20 each on the BSE.
The government currently holds 75.15 per cent in HAL, which is a Central Public Sector Enterprises (CPSE) under the Defence Ministry.
The proceeds from HAL OFS would add up to the government's disinvestment kitty for the current fiscal.
The government has so far mopped up Rs 31,106.64 crore from disinvestment and share buyback in CPSEs.
The government had last month pegged a lower revised estimates of disinvestment revenue estimates for the current fiscal at Rs 50,000 crore, against the budget target of Rs 65,000 crore.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.